Meta-analysis
Oct 2026
Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.
OBJECTIVES Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) remain at substantial risk of recurrent ischemic events, despite guideline-recommended antithrombotic therapy. Factor XIa (FXIa) inhibitors may reduce thrombotic risk while preserving hemostasis. METHODS We systematically sea...
A. Katsanos, A. Shoamanesh, L. Palaiodimou et al.
· Neurology · 0 citations